In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)
- 31 July 2005
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (3) , 173-179
- https://doi.org/10.1016/j.diagmicrobio.2005.06.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infectionsInternational Journal of Antimicrobial Agents, 2004
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Novel antibacterial agents for the treatment of serious Gram-positive infectionsExpert Opinion on Investigational Drugs, 2003
- Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1Antimicrobial Agents and Chemotherapy, 2003
- Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia.Journal of Antimicrobial Chemotherapy, 2002
- Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the USInternational Journal of Antimicrobial Agents, 2002
- In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in SpainAntimicrobial Agents and Chemotherapy, 2002
- Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)Journal of Antimicrobial Chemotherapy, 2002
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000